King-Jones Heidy's Form 4 filing
Spyre Therapeutics, Inc. (SYRE) · filed Sep 3, 2026
- Accession no.
- 0001636282-26-000111
- Filed
- Sep 3, 2026, 9:34 PM ET
- Trade date
- Sep 1-2, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.48M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| King-Jones HeidyCIK 0001794898 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | MOption exerciseAcquired | +27,999 | $14.50 | +$405,985.5 | 30,844 | Direct | |
| Sep 1, 2026 | Common Stock | SSaleDisposed | −4,845 | $86.40 | −$418,608 | 25,999 | Direct | |
| Sep 1, 2026 | Common Stock | SSaleDisposed | −16,548 | $87.20 | −$1,442,985.6 | 9,451 | Direct | |
| Sep 1, 2026 | Common Stock | SSaleDisposed | −6,206 | $88.17 | −$547,183.02 | 3,245 | Direct | |
| Sep 1, 2026 | Common Stock | SSaleDisposed | −400 | $89.38 | −$35,752 | 2,845 | Direct | |
| Sep 2, 2026 | Common Stock | MOption exerciseAcquired | +400 | $14.50 | +$5,800 | 3,245 | Direct | |
| Sep 2, 2026 | Common Stock | SSaleDisposed | −400 | $90.00 | −$36,000 | 2,845 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | MOption exerciseDisposed | −27,999 | $0.00 | $0 | 511,811 | Direct | |
| Sep 2, 2026 | Common Stock | MOption exerciseDisposed | −400 | $0.00 | $0 | 511,411 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.